GBM-associated B cells exhibited immunosuppressive activities toward stimulated CD8+ T cells, and their pathophysiological significance was underlined by prolonged animal survival after local administration of B cell-depleting immunotherapy [94]. The gene discussed is CD8A; the disease is glioblastoma.